Acquisition significantly expands Flagship’s portfolio of biomarker and analytics services BROOMFIELD, Colo., Aug. 31, 2022 /PRNewswire/ — Flagship Biosciences, Inc., a leader in spatial biology and biomarker analytics services, announced the acquisition of Interpace Pharma Solutions®…
Related Articles

News
Efforts to Control Prescription Drug Pricing Harms Collaborative Work to Advance Patient Care with Health Innovations
September 18, 2023
UCBN
News, Syndication
Comments Off on Efforts to Control Prescription Drug Pricing Harms Collaborative Work to Advance Patient Care with Health Innovations
Elyse Blazevich, President & CEO, Colorado BioScience Association Colorado’s life sciences community and our state leaders share an unwavering commitment to improving patient lives and making sure Colorado remains Colorado—where quality of life and livelihood […]

News
Healthcare Receivables Group Joins Revenue Cycle Leader Wakefield to Strengthen Accounts Receivable Service Lines
January 17, 2023
UCBN
News
Comments Off on Healthcare Receivables Group Joins Revenue Cycle Leader Wakefield to Strengthen Accounts Receivable Service Lines
AURORA, Colo., Jan. 17, 2023 /PRNewswire/ — Wakefield, a leading healthcare revenue cycle solutions company, announced today that Healthcare Receivables Group (HRG) has joined the Wakefield organization. Together, the two companies will leverage combined capabilities […]

News
Intricate Look at Neurons Brings Wonder and Intrigue to Anatomy Lesson
November 9, 2022
UCBN
News
Comments Off on Intricate Look at Neurons Brings Wonder and Intrigue to Anatomy Lesson
Visitors from a local high school held real human brains, virtually dissected a body donated to science and gazed at a 10-foot rendition of optic neurons during a recent anatomy lesson with an artistic twist […]